On Friday the Food and Drug Administration launched its first hearing on Cannabidiol (CBD) products. CBD has become widely available in smoke shops and health food stores in tinctures, creams, seltzers and other products. The acting head of the FDA questioned how much CBD is safe to consume among other questions. The products have been purported to treat a number of ailments from inflammation to anxiety and insomnia. But what does the science tell us about CBD's effects on the brain and body?
CBD is the non-psychoactive ingredient found in the cannabis plant. Unlike tetrahydrocannabinol (THC), there is no high with CBD. A few small clinical trials have launched examining the effects of CBD on anxiety, depression and other health problems, and a study of Epidiolex is showing promise for the treatment of a rare form of epilepsy. But large studies comparing CBD with placebos have been rare.
Joining Cincinnati Edition to discuss the various CBD products on the market and the question of their health benefits are QC Infusion Co-founder Rob Ryan; University of Cincinnati Medical Center Epilepsy Center Director College of Medicine, Department of Neurology and Rehabilitation Medicine Professor Michael Privitera, MD; and Icahn School of Medicine at Mount Sinai Addiction Institute Director Yasmin Hurd.
Listen to Cincinnati Edition live at noon M-F. Never miss an episode by subscribing to our podcast on your favorite provider. And if you have a chance, please rate, review and share with friends: